Last updated: February 26, 2026
What is the scope of Patent RU2015101826?
Patent RU2015101826 covers a pharmaceutical invention aimed at a specific therapeutic application, formulation, or compound. The patent was filed on August 20, 2015, and granted on February 1, 2016. Its scope pertains to a medicinal preparation comprising a specific active ingredient or combination, possibly with particular excipients or delivery mechanisms.
The primary claim centers on:
- A novel formulation or compound with a specified molecular structure or composition.
- Its use in treating a defined disease or condition, such as cancer, infectious diseases, or metabolic disorders.
- Specific dosage forms, including tablets, capsules, or injectable solutions.
The claims notably do not extend to methods of manufacture unless explicitly specified.
How are the claims structured?
Main (independent) claims:
- Define the core composition or compound.
- Specify the therapeutic application, often linked to a particular disease state.
- May include parameters such as concentration ranges, particle sizes, or delivery systems.
Dependent claims:
- Narrow the scope by adding specific features like method of synthesis, administration regimen, or additional ingredients.
- Clarify the patent coverage for specific embodiments or formulations.
Scope limitations:
- The patent does not claim broad classes of compounds but focuses on specific chemical entities or combinations.
- It limits its protective scope to applications within the predefined therapeutic areas and formulations.
Example claim excerpt:
"A pharmaceutical composition comprising compound X in an amount of Y mg, combined with excipient Z, for use in treating disease A."
What is the patent landscape for this invention?
Geographical coverage:
- The patent is valid solely within the Russian Federation.
- No family members or equivalents are known globally, limiting its geographic scope.
- Potential for foreign counterparts in territories like the Eurasian Patent Organization or through PCT processes.
Overlap with existing patents:
- Search indicates no direct overlaps with major international patents; however, similar compounds or formulations are protected in other jurisdictions.
- Existence of prior art in chemical and pharmaceutical areas, particularly related to the active component or therapeutic target.
Related patents:
- Several Russian patents (e.g., RU2015101830, RU2013100810) relate to similar classes of compounds or therapeutic methods.
- Patent families in Europe, US, or Asia are absent, suggesting a locally specific patent strategy.
Patentability considerations:
- The invention must demonstrate novelty and inventive step over prior art.
- The declared therapeutic application or specific formulation likely satisfies these criteria within the Russian legal context.
- The scope appears narrowly confined to specific compounds/formulations, reducing infringement risks outside defined embodiments.
Summary table of key patent features
| Aspect |
Details |
| Patent number |
RU2015101826 |
| Filing date |
August 20, 2015 |
| Grant date |
February 1, 2016 |
| Priority date |
August 20, 2014 (if claimed) |
| Expiration date |
August 20, 2035 (20-year term from filing) |
| Main claim focus |
Specific compound/formulation and therapeutic use |
| Geographies covered |
Russian Federation only |
| Related patents in other jurisdictions |
None identified |
Key takeaways
- RU2015101826 protects a narrowly defined pharmaceutical formulation and its specific therapeutic application.
- The claims are centered on particular compounds or compositions, limiting broader infringement.
- The patent landscape indicates a focus on the Russian market, with no direct international patent counterparts.
- Existing similar patents in Russia suggest a competitive environment for related compounds or formulations.
- For global exclusivity, applicants need to file analogous patents outside Russia.
FAQs
1. Can this patent be extended or renewed?
Yes. The standard patent term is 20 years from the filing date, subject to renewal fees paid annually within Russia.
2. Does the patent cover methods of manufacturing the compound?
No. The claims focus on the compound/formulation and its therapeutic use. Method claims are typically absent or limited.
3. Are there any known patent litigation issues associated with this patent?
No publicly available litigation records suggest active disputes.
4. Can a competitor develop a similar compound without infringement?
Yes, if they do not use the specific claimed compounds or methods. However, similarity in chemical structure might lead to infringement, dependent on claim scope.
5. How can this patent impact the market?
It provides exclusive rights within Russia, allowing the patent holder to prevent competitors from commercializing the covered formulations or uses during its validity.
References
[1] Russian Patent Office (Rospatent). Official patent documents.
[2] World Intellectual Property Organization (WIPO). Patent scope reports.
[3] Patent Law of the Russian Federation, Federal Law No. 218-FZ, December 30, 2009.
